Multi-protease dual-fragmentation antibody sequencing
downstream-application · Protease strategy
Multi-protease dual-fragmentation antibody sequencing: downstream-application · Protease strategy. Direct de novo sequencing of monoclonal IgG from the purified product with a panel of complementary proteases and both stepped HCD and EThcD on every…
Direct de novo sequencing of monoclonal IgG from the purified product with a panel of complementary proteases and both stepped HCD and EThcD on every precursor, demonstrated on the anti-FLAG-M2 antibody.
| Kind | downstream-application |
| Deep learning | no |
| Acquisition | DDA |
| Family | Protease strategy |
| Application area | Antibodyomics |
Data
What the papers describing this method trained it on and reported its results on, as each paper states it. A version is named only where the paper names one.
Evaluated on
Also used, purpose not recorded
- Anti-FLAG-M2 antibody sequencing (as deposited) · 2021 peer-reviewed, 2021 preprint, 2024 thesis
- Bottom-up data - sequencing (as deposited) · 2024 thesis
- Direct mass spectrometry-based detection and antibody sequencing of Monoclonal Gammopathy of Undetermined Significance from patient serum (as deposited) · 2024 thesis
- Sequencing the anti-MUC1 hybridoma antibody 139H2 (as deposited) · 2024 thesis
- Template-based assembly of proteomic short reads for de novo antibody sequencing and repertoire profiling (as deposited) · 2024 thesis
Papers describing it (3)
- Mass spectrometry-based de novo sequencing of the anti-FLAG-M2 antibody using multiple proteases and a dual fragmentation scheme (2021, bioRxiv, preprint)
- Mass Spectrometry-Based De Novo Sequencing of Monoclonal Antibodies Using Multiple Proteases and a Dual Fragmentation Scheme (2021, Journal of Proteome Research, peer-reviewed)
- De novo antibody sequencing based on mass spectrometry (2024, thesis)